Lyphe is proud to announce the launch of its new low-cost medical cannabis line, Noidecs Vital, designed to address affordability issues for medical patients.
Recognising the financial barriers many patients face in accessing cannabis treatments, the Noidecs Vital line will provide a cost-effective option that does not compromise on quality.
“We understand that cost can be a significant barrier for many patients seeking the therapeutic benefits of medical cannabis.” Notes Sophie Gamwell, Managing Director of Lyphe UK.
“The Noidecs Vital product line is designed to alleviate this burden, ensuring that all patients, regardless of their financial situation, have access to the high-quality medical cannabis they need for their health and well-being.“
With more strains to follow, this new line underscores Lyphe UK’s commitment to making medical cannabis more accessible and affordable, ensuring that more patients can benefit from its therapeutic properties.
About Dispensary Green
Dispensary Green is the UK’s leading medical cannabis pharmacy that dispatches across the UK using a dedicated licensed courier. (England, Scotland, Wales, and the Highlands).
The pharmacy has been in operation since 2019 and has dispatched over 300,000 items primarily in private medical cannabis prescriptions.
Dispensary Green carries an unrivalled product range to ensure the needs of its patients are met, which has now been strengthened with the addition of Noidecs Vital.
For media inquiries, please contact: Bojan Ambrus via [email protected]
The post Lyphe UK to Launch Noidecs Vital, a New Low-Cost Medical Cannabis Line appeared first on Cannabis Health News.
Go to Source
Author: Sponsored features editor
